Serological characterization of dengue virus infections observed among dengue hemorrhagic fever/dengue shock syndrome cases in upper Myanmar

Journal of Medical Virology

Volumn 85, Issue 7, 2013, Pages 1258-1266

  Ngwe Tun, Mya Myat ^a   Thant, Kyaw Zin ^a,b   Inoue, Shingo ^a   Kurosawa, Yae ^c   Lwin, Yee Yee ^b   Lin, Sanda ^b   Aye, Kay Thi ^b   Thet Khin, Pe ^d   Myint, Tin ^e   Htwe, Khin ^f   Mapua, Cynthia A ^g   Natividad, Filipinas F ^g   Hirayama, Kenji ^a   Morita, Kouichi ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b Nagasaki University ^*  (Myanmar)

^c PENTAX Corporation   (Japan)

^d University of Medicine   (Myanmar)

^e University of Medicine II   (Myanmar)

^f Department of Child Health   (Myanmar)

^g ST LUKE S MEDICAL CENTER   (Philippines)

Author keywords

Dengue virus; DHF; DSS; Primary DENV infection; Secondary DENV infection

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ARTICLE; CHILD; CLINICAL TRIAL; COMPARATIVE STUDY; DENGUE; DENGUE VIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GROUPS BY AGE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INFANT; MAJOR CLINICAL STUDY; MALE; MYANMAR; PRESCHOOL CHILD; PRIMARY INFECTION; SCHOOL CHILD; SECONDARY INFECTION; SERODIAGNOSIS; SEROLOGY;

DENGUE VIRUS; DHF; DSS; PRIMARY DENV INFECTION; SECONDARY DENV INFECTION;

ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; DENGUE; DENGUE VIRUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFANT; MALE; MYANMAR; NEUTRALIZATION TESTS;

EID: 84878217643     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23577     Document Type: Article

References (49)

1. Aaskov J, Buzacott K, Thu HM, Lowry K, Holmes EC. 2006. Long-term transmission of defective RNA viruses in humans and Aedes mosquitoes. Science 311:236-238.
2. Bundo K, Igarashi A. 1985. Antibody-capture ELISA for detection of immunoglobulin M antibodies in sera from Japanese encephalitis and dengue hemorrhagic fever patients. J Virol Methods 11:15-22.
3. Bundo-Morita K, Torres CA, Chanyasanha C, Linn ML, Igarashi A. 1986. Antibody response in Japanese encephalitis and dengue hemorrhagic fever patients measured by indirect ELISA. Trop Med 28:101-114.
4. Burke DS, Nisalak A, Johnson DE, Scott RM. 1988. A prospective study of dengue infections in Bangkok. Am J Trop Med Hyg 38:172-180.
5. Chaturvedi UC, Shrivastava R. 2004. Dengue haemorrhagic fever: A global challenge. Indian J Med Microbiol 22:5-6.
6. De Rivera IL, Parham L, Murillo W, Moncada W, Vazquez S. 2008. Humoral immune response of dengue hemorrhagic fever cases in children from Tegucigalpa, Honduras. Am J Trop Med Hyg 79:262-266.
7. Endy TP, Nisalak A, Chunsuttitwat S, Vaughn DW, Green S, Ennis FA, Rothman AL, Libraty DH. 2004. Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand. J Infect Dis 189:990-1000.
8. Espada-Murao LA, Morita K. 2011. Delayed cytosolic exposure of Japanese encephalitis virus double-stranded RNA impedes interferon activation and enhances viral dissemination in porcine cells. J Virol 85:6736-6749.
9. Fink J, Gu F, Vasudevan SG. 2006. Role of T cells, cytokines and antibody in dengue fever and dengue haemorrhagic fever. Rev Med Virol 16:263-275.
10. Fox A, Le NM, Simmons CP, Wolbers M, Wertheim HF, Pham TK, Tran TH, Trinh TM, Nguyen TL, Nguyen VT, Nguyen DH, Farrar J, Horby P, Taylor WR, Nguyen VK. 2011. Immunological and viral determinants of dengue severity in hospitalized adults in Ha Noi, Viet Nam. PLoS Negl Trop Dis 5:e967.
11. Graham RR, Juffrie M, Tan R, Hayes CG, Laksono I, Ma'roef C, Erlin Sutaryo, Porter KR, Halstead SB. 1999. A prospective seroepidemiologic study on dengue in children four to nine years of age in Yogyakarta, Indonesia I. Studies in 1995-1996 Am J Trop Med Hyg 61:412-419.
12. Gubler DJ, Suharyono W, Tan R, Abidin M, Sie A. 1981. Viraemia in patients with naturally acquired dengue infection. Bull WHO 59:623-630.
13. Guzmán MG, Kourí G, Halstead SB. 2000. Do escape mutants explain rapid increases in dengue case-fatality rates within epidemics? Lancet 355:1902-1903.
14. Halstead SB, Nimmannitya S, Cohen SN. 1970. Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered. Yale J Biol Med 42:311-328.
15. Halstead SB. 1981. The pathogenesis of dengue. Molecular epidemiology in infectious disease. Am J Epidemiol 114:632-648.
16. Halstead SB, Rojanasuphot S, Sangkawibha N. 1983. Original antigenic sin in dengue. Am J Trop Med Hyg 32:154-156.
17. Halstead SB. 2007. Dengue. Lancet 370:1644-1652.
18. Henchal EA, Putnak JR. 1990. The dengue viruses. Clin Microbiol Rev 3:376-396.
19. Inoue S, Alonzo MT, Kurosawa Y, Mapua CA, Reyes JD, Dimaano EM, Alera MT, Saito M, Oishi K, Hasebe F, Matias RR, Natividad FF, Morita K. 2010. Evaluation of a dengue IgG indirect enzyme-linked immunosorbent assay and a Japanese encephalitis IgG indirect enzyme-linked immunosorbent assay for diagnosis of secondary dengue virus infection. Vector Borne Zoonotic Dis 10:143-150.
20. Islam MA, Ahmed MU, Begum N, Chowdhury NA, Khan AH, Parquet Mdel C, Bipolo S, Inoue S, Hasebe F, Suzuki Y, Morita K. 2006. Molecular characterization and clinical evaluation of dengue outbreak in 2002 in Bangladesh. Jpn J Infect Dis 59:85-91.
21. Karyanti MR. 2011. Clinical manifestations and hematological and serological findings in children with dengue infection. Paediatr Indones 51:157-162.
22. Kinoshita H, Mathenge EG, Hung NT, Huong VT, Kumatori A, Yu F, Parquet MC, Inoue S, Matias RR, Natividad FF, Morita K, Hasebe F. 2009. Isolation and characterization of two phenotypically distinct dengue type-2 virus isolates from the same dengue hemorrhagic fever patient. Jpn J Infect Dis 62:343-350.
23. Kouri GP, Guzmán MG, Bravo JR. 1987. Why dengue haemorrhagic fever in Cuba? 2. An integral analysis. Trans R Soc Trop Med Hyg 81:821-823.
24. Kurane I, Takasaki T. 2001. Dengue fever and dengue haemorrhagic fever: Challenges of controlling an enemy still at large. Rev Med Virol 11:301-311.
25. Libraty DH, Endy TP, Houng HS, Green S, Kalayanarooj S, Suntayakorn S, Chansiriwongs W, Vaughn DW, Nisalak A, Ennis FA, Rothman AL. 2002. Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections. J Infect Dis 185:1213-1221.
26. Murgue B, Roche C, Chungue E, Deparis X. 2000. Prospective study of the duration and magnitude of viraemia in children hospitalized during the 1996-1997 dengue-2 outbreak in French Polynesia. J Med Virol 60:432-438.
27. Nguyen TH, Lei HY, Nguyen TL, Lin YS, Huang KJ, Le BL, Lin CF, Yeh TM, Do QH, Vu TQ, Chen LC, Huang JH, Lam TM, Liu CC, Halstead SB. 2004. Dengue hemorrhagic fever in infants: A study of clinical and cytokine profiles. J Infect Dis 189:221-232.
28. Nisalak A, Endy TP, Nimmannitya S, Kalayanarooj S, Thisayakorn U, Scott RM, Burke DS, Hoke CH, Innis BL, Vaughn DW. 2003. Serotype-specific dengue virus circulation and dengue disease in Bangkok, Thailand from 1973 to 1999. Am J Trop Med Hyg 68:191-202.
29. Okamoto K, Kinoshita H, Parquet MC, Raekiansyah M, Kimura D, Yui K, Islam MA, Hasebe F, Morita K. 2012. Dengue virus strain DEN2 16681 utilizes a specific glycochain of syndecan-2 proteoglycan as a receptor. J Gen Virol 93:761-770.
30. Pongsumpun P, Yoksan S, Tang IM. 2002. A comparison of the age distributions in the dengue hemorrhagic fever epidemics in Santiago de Cuba (1997) and Thailand (1998) Southeast Asian J Trop Med Public Health 33:255-258.
31. Rigau-Pérez JG, Clark GC, Gubler DJ, Reiter P, Sanders EJ, Vorndam AV. 1998. Dengue and dengue haemorrhagic fever. Lancet 352:971-977.
32. Rosen L. 1977. The Emperor's New Clothes revisited, or reflections on the pathogenesis of dengue hemorrhagic fever. Am J Trop Med Hyg 26:337-343.
33. Sangkawibha N, Rojanasuphot S, Ahandrik S, Viriyapongse S, Jatanasen S, Salitul V, Phanthumachinda B, Halstead SB. 1984. Risk factors in dengue shock syndrome: A prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. Am J Epidemiol 120:653-669.
34. Simmons CP, Chau TN, Thuy TT, Tuan NM, Hoang DM, Thien NT, Lien Le B, Quy NT, Hieu NT, Hien TT, McElnea C, Young P, Whitehead S, Hung NT, Farrar J. 2007. Maternal antibody and viral factors in the pathogenesis of dengue virus in infants. J Infect Dis 196:416-424.
35. Sriprom M, Pongsumpun P, Yoksan S, Barbazan P, Gonzalez JP, Tang IM. 2003. Dengue haemorrhagic fever in Thailand, 1998-2003: Primary or secondary infection. Dengue Bull 27:39-45.
36. Thein S. 1991. Dengue haemorrhagic fever in Myanmar. DMR Bull 5:1-14.
37. Thein S, Aaskov J, Myint TT, Shwe TN, Saw TT, Zaw A. 1993. Changes in levels of anti-dengue virus IgG subclasses in patients with disease of varying severity. J Med Virol 40:102-106.
38. Thein S, Aung MM, Shwe TN, Aye M, Zaw A, Aye K, Aye KM, Aaskov J. 1997. Risk factors in dengue shock syndrome. Am J Trop Med Hyg 56:566-572.
39. Thu HM, Lowry K, Myint TT, Shwe TN, Han AM, Khin KK, Thant KZ, Thein S, Aaskov J. 2004. Myanmar dengue outbreak associated with displacement of serotypes 2, 3 and 4 by dengue 1. Emerg Infect Dis 10:593-597.
40. Thu HM, Jones A, Han AM, Aye KM, Aye KT, Mya T, Shwe TT, Mar W, Aaskov J. 2008. Molecular epidemiology of dengue 3 viruses in Myanmar [abstract 28]. Program and abstracts of the Myanmar health research congress (Yangon). Union of Myanmar: Ministry of Health.
41. Tupasi TE, Montalban CS, Zeta MRM, Moriles RC, Paladin FE. 1987. Virological and clinical studies in dengue infection. Phil J Microbiol Infect Dis 16:1-5.
42. Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, Suntayakorn S, Rothman AL, Ennis FA, Nisalak A. 1997. Dengue in the early febrile phase: Viremia and antibody responses. J Infect Dis 176:322-330.
43. Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, Suntayakorn S, Endy TP, Raengsakulrach B, Rothman AL, Ennis FA, Nisalak A. 2000. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis 181:2-9.
44. Wang WK, Chao DY, Kao CL, Wu HC, Liu YC, Li CM, Lin SC, Ho ST, Huang JH, King CC. 2003. High levels of plasma dengue viral load during defervescence in patients with dengue hemorrhagic fever: Implications for pathogenesis. Virology 305:330-338.
45. Wang WK, Chen HL, Yang CF, Hsieh SC, Juan CC, Chang SM, Yu CC, Lin LH, Huang JH, King CC. 2006. Slower rates of clearance of viral load and virus-containing immune complexes in patients with dengue hemorrhagic fever. Clinc Infect Dis 43:1023-1030.
46. Watt G, Jongsakul K. 2003. Acute undifferentiated fever caused by infection with Japanese encephalitis virus. Am J Trop Med Hyg 68:704-706.
47. World Health Organization. 1997. Dengue haemorrhagic fever: Diagnosis, treatment, prevention and control 2nd edition. Geneva: WHO.
48. World Health Organization. 2008. Joint plan of action scaling up dengue prevention and control for the cyclone nargis-affected populations (June-September 2008). p 13.
49. World Health Organization. 2012. Impact of dengue. Available at: http://www.who.int/csr/disease/dengue/impact/en/.